LENZ Therapeutics Inc.
LENZ | NASDAQ
$4.08
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$4.08
$0 (0.00%)
Pre-market:
Sep 22, 2026, 5:02 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 19.09M | n/a | n/a | 15M | n/a | n/a |
Cost of Revenue | 705K | 58K | n/a | n/a | 734K | 121K |
Gross Profit | 18.38M | -58K | n/a | 15M | -734K | -121K |
Operating Income | -91.14M | -58.61M | -72.43M | -10.48M | -60.44M | -13.5M |
Interest Income | 9.76M | 8.55M | 2.19M | n/a | n/a | n/a |
Pretax Income | -81.63M | -49.77M | -70.15M | -10.46M | -70.76M | -68.37M |
Net Income | -82.13M | -49.77M | -69.97M | -10.81M | -70.76M | -68.37M |
Selling & General & Admin | 90.85M | 28.75M | 12.93M | 4.36M | 21.78M | 4.26M |
Research & Development | 18.67M | 29.8M | 59.5M | 21.13M | 37.93M | 9.12M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 109.52M | 58.55M | 72.43M | 25.48M | 59.71M | 13.38M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 40K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 110.23M | 58.61M | 72.43M | 25.48M | 60.44M | 13.5M |
Income Tax Expense | 502K | 1K | -179K | 347K | n/a | n/a |
Shares Outstanding (Basic) | 28.81M | 21.28M | 8.15M | 7.84M | 8.29M | 8.3M |
Shares Outstanding (Diluted) | 28.81M | 21.28M | 8.15M | 7.84M | 8.29M | 8.3M |
EPS (Basic) | -2.85 | -2.34 | -15.30 | -12.89 | -8.54 | -8.24 |
EPS (Diluted) | -2.85 | -2.34 | -15.30 | -12.89 | -8.54 | -8.24 |
EBITDA | -81.34M | -49.71M | -70.13M | -10.46M | -70.03M | -68.21M |
EBIT | -81.63M | -49.77M | -70.15M | -10.46M | -70.76M | -68.33M |
Depreciation & Amortization | 287K | 58K | 15K | 8K | 734K | 121K |
Add to Watchlist
Select watchlists to add or remove LENZ